MD Anderson Cancer Center UTHealth
Graduate School of Biomedical Sciences

High Impact Student Publications - Current Students

(This is not an exhaustive list - page currently under construction)

Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy.
Hsieh CE, Venkatesulu BP, Lee CH, Hung SP, Wong PF, Aithala SP, Kim BK, Rao A, Tung-Chieh Chang J, Tsang NM, Wang CC, Lee CC, Lin CC, Tseng JH, Chou WC, Wang YC, Krishnan S, Hong JH.
Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):73-86. doi: 10.1016/j.ijrobp.2019.02.032. Epub 2019 Feb 21.
PMID: 30797890

Prognostic Value of Tumor Heterogeneity and SUVmax of Pretreatment 18F-FDG PET/CT for Salivary Gland Carcinoma With High-Risk Histology.                      
Cheng NM, Hsieh CE, Liao CT, Ng SH, Wang HM, Fang YD, Chou WC, Lin CY, Yen TC.
Clin Nucl Med. 2019 May;44(5):351-358. doi: 10.1097/RLU.0000000000002530.
PMID: 30932974

Pretreatment Primary Tumor and Nodal SUVmax Values on 18F-FDG PET/CT Images Predict Prognosis in Patients With Salivary Gland Carcinoma.
Hsieh CE, Cheng NM, Chou WC, Venkatesulu BP, Chou YC, Liao CT, Yen TC, Lin CY.
Clin Nucl Med. 2018 Dec;43(12):869-879. doi: 10.1097/RLU.0000000000002287.
PMID:  30273205

Pretreatment Primary Tumor SUVmax on 18F-FDG PET/CT Images Predicts Outcomes in Patients With Salivary Gland Carcinoma Treated With Definitive Intensity-Modulated Radiation Therapy.
Hsieh CE, Ho KC, Hsieh CH, Yen TC, Liao CT, Wang HM, Lin CY.
Clin Nucl Med. 2017 Sep;42(9):655-662. doi: 10.1097/RLU.0000000000001740.
PMID:  28650891

let-7 Modulates Chromatin Configuration and Target Gene Repression through Regulation of the ARID3B Complex.
Liao TT, Hsu WH, Ho CH, Hwang WL, Lan HY, Lo T, Chang CC, Tai SK, Yang MH.
Cell Rep. 2016 Jan 26;14(3):520-533. doi: 10.1016/j.celrep.2015.12.064. Epub 2016 Jan 14.
PMID:  26776511

Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells.
Chang CC, Hsu WH, Wang CC, Chou CH, Kuo MY, Lin BR, Chen ST, Tai SK, Kuo ML, Yang MH.
Cancer Res. 2013 Jul 1;73(13):4147-57. doi: 10.1158/0008-5472.CAN-12-4085. Epub 2013 May 16. Erratum in: Cancer Res. 2017 Jun 1;77(11):3127.
PMID:  23687336 

Localized Treatment with Oncolytic Adenovirus Delta-24-RGDOX Induces Systemic Immunity against Disseminated Subcutaneous and Intracranial Melanomas.
Jiang H, Shin DH, Nguyen TT, Fueyo J, Fan X, Henry V, Carrillo CC, Yi Y, Alonso MM, Collier TL, Yuan Y, Lang FF, Gomez-Manzano C.
Clin Cancer Res. 2019 Nov 15;25(22):6801-6814. doi: 10.1158/1078-0432.CCR-19-0405. Epub 2019 Aug 27.
PMID:  31455679